Status:

UNKNOWN

Thrombelastogram in Patients Receiving Antiplatelet Medication Undergoing Cardiac Surgery

Lead Sponsor:

Sheba Medical Center

Conditions:

Bleeding

Eligibility:

All Genders

18-90 years

Brief Summary

Study Objective is to correlate the results of preoperative platelet mapping derived from modified TEG with clinically significant postoperative bleeding and consumption of blood products.

Detailed Description

Study Design: Prospective observational study with blinded assessment of study endpoint variables. Collection of information concerning study endpoints will be performed by the investigator blinded t...

Eligibility Criteria

Inclusion

  • Patients undergoing cardiac surgery with the history of aspirin and/or ADP receptor antagonist for at least 7 days prior the surgery

Exclusion

  • Emergent surgery
  • Heart transplant surgery
  • Implantation of ventricular assist devices
  • Enrollment into conflicting study

Key Trial Info

Start Date :

May 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2008

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT00778492

Start Date

May 1 2008

End Date

December 1 2008

Last Update

October 23 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sheba Medical Center

Tel Litwinsky, Israel, 52621

Thrombelastogram in Patients Receiving Antiplatelet Medication Undergoing Cardiac Surgery | DecenTrialz